Podcasts · PsychRounds: The Psychiatry Podcast

VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)

21 Mar 2026 · 17 min

Episode VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)

0:00 17:19

Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).

References:

https://pubmed.ncbi.nlm.nih.gov/41626799/

https://www.ncbi.nlm.nih.gov/books/NBK548187/

https://pubmed.ncbi.nlm.nih.gov/41626799/

Links in the notes 2

https://pubmed.ncbi.nlm.nih.gov/41626799/
https://www.ncbi.nlm.nih.gov/books/NBK548187/

The episode on the publisher’s site (opens in a new tab)

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.